Cargando…
A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology
Gonadotropins extracted from the urine of post-menopausal women have traditionally been used to stimulate folliculogenesis in the treatment of infertility and in assisted reproductive technology (ART). Products, such as human menopausal gonadotropin (hMG), consist not only of a mixture of the hormon...
Autores principales: | Ezcurra, Diego, Humaidan, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287577/ https://www.ncbi.nlm.nih.gov/pubmed/25280580 http://dx.doi.org/10.1186/1477-7827-12-95 |
Ejemplares similares
-
Final Oocyte Maturation in Assisted Reproduction with Human Chorionic
Gonadotropin and Gonadotropin-releasing Hormone agonist (Dual
Trigger)
por: de Oliveira, Sofia Andrade, et al.
Publicado: (2016) -
Advancing or postponing the day of human chorionic gonadotropin does not matter for the outcome in assisted reproductive technology
por: Pratap, Deepika, et al.
Publicado: (2014) -
Human Chorionic Gonadotropin: The Pregnancy Hormone and More
por: Theofanakis, Charalampos, et al.
Publicado: (2017) -
Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
por: Eser, Ahmet, et al.
Publicado: (2018) -
Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2017)